Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Mackinnon

Showing results (111-120 of 130) with videos related to

Pageof 13
Sort By:
The New England Journal of Medicine|April 28, 1994
Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantationE B Papadopoulos, M Ladanyi, D Emanuel, et al.
Bone Marrow Transplantation|January 10, 2002
Excessive T cell depletion of peripheral blood stem cells has an adverse effect upon outcome following allogeneic stem cell transplantationR Chakraverty, S Robinson, K Peggs, et al.
Bone Marrow Transplantation|January 1, 1993
Matched unrelated donor bone marrow transplantation for chronic myeloid leukaemia in chronic phase: comparison of ex vivo and in vivo T-cell depletionJ O Cullis, R M Szydlo, N C Cross, et al.
Blood|August 15, 1995
Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host diseaseS Mackinnon, E B Papadopoulos, M H Carabasi, et al.
CJC Open|June 23, 2022
Real-World Insights Into Evolocumab Use in Patients With Hyperlipidemia: Canadian Analysis From the ZERBINI StudyMilan Gupta, G B John Mancini, Rajvi J Wani, et al.
British Journal of Haematology|March 10, 2005
Use of 18F-FDG positron emission tomography following allogeneic transplantation to guide adoptive immunotherapy with donor lymphocyte infusionsD P Hart, I Avivi, K J Thomson, et al.
Bone Marrow Transplantation|January 16, 2008
Superiority of reduced-intensity allogeneic transplantation over conventional treatment for relapse of Hodgkin's lymphoma following autologous stem cell transplantationK J Thomson, K S Peggs, P Smith, et al.
Current Topics in Medicinal Chemistry|February 7, 2003
Traditionally-used antimalarials from the MeliaceaeS Omar, J Zhang, S MacKinnon, et al.
Cardiology and Therapy|October 7, 2023
Real-World Insights into Evolocumab Use in Patients with Hyperlipidemia Across Five Countries: Analysis from the ZERBINI StudyMilan Gupta, Rajvi J Wani, Khalid Al Faraidy, et al.
Bone Marrow Transplantation|January 27, 2004
Outbreaks of infectious diseases in stem cell transplant units: a silent cause of death for patients and transplant programmesS McCann, J L Byrne, M Rovira, et al.
Pageof 13

Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
The New England Journal of Medicine|April 28, 1994
Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantationE B Papadopoulos, M Ladanyi, D Emanuel, et al.
Bone Marrow Transplantation|January 10, 2002
Excessive T cell depletion of peripheral blood stem cells has an adverse effect upon outcome following allogeneic stem cell transplantationR Chakraverty, S Robinson, K Peggs, et al.
Bone Marrow Transplantation|January 1, 1993
Matched unrelated donor bone marrow transplantation for chronic myeloid leukaemia in chronic phase: comparison of ex vivo and in vivo T-cell depletionJ O Cullis, R M Szydlo, N C Cross, et al.
Blood|August 15, 1995
Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host diseaseS Mackinnon, E B Papadopoulos, M H Carabasi, et al.
CJC Open|June 23, 2022
Real-World Insights Into Evolocumab Use in Patients With Hyperlipidemia: Canadian Analysis From the ZERBINI StudyMilan Gupta, G B John Mancini, Rajvi J Wani, et al.
British Journal of Haematology|March 10, 2005
Use of 18F-FDG positron emission tomography following allogeneic transplantation to guide adoptive immunotherapy with donor lymphocyte infusionsD P Hart, I Avivi, K J Thomson, et al.
Bone Marrow Transplantation|January 16, 2008
Superiority of reduced-intensity allogeneic transplantation over conventional treatment for relapse of Hodgkin's lymphoma following autologous stem cell transplantationK J Thomson, K S Peggs, P Smith, et al.
Current Topics in Medicinal Chemistry|February 7, 2003
Traditionally-used antimalarials from the MeliaceaeS Omar, J Zhang, S MacKinnon, et al.
Cardiology and Therapy|October 7, 2023
Real-World Insights into Evolocumab Use in Patients with Hyperlipidemia Across Five Countries: Analysis from the ZERBINI StudyMilan Gupta, Rajvi J Wani, Khalid Al Faraidy, et al.
Bone Marrow Transplantation|January 27, 2004
Outbreaks of infectious diseases in stem cell transplant units: a silent cause of death for patients and transplant programmesS McCann, J L Byrne, M Rovira, et al.
Pageof 13